Alpha Cognition Inc. Fair Value Adjustment of Warrants
Alpha Cognition Inc. (ACOG) reported Fair Value Adjustment of Warrants of -$3.67 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-31
- Alpha Cognition Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$3.67M.
- Alpha Cognition Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $5.17M.
- Alpha Cognition Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was -$591.74K, a 214.73% decline year-over-year.
- Alpha Cognition Inc. fair value adjustment of warrants for the quarter ending 2024-06-30 was -$187.06K, a 360.32% decline year-over-year.
| Period end | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | -$3.67M 10-Q · filed 2025-11-13 | $1.50M derived: sum of 2 quarters · filed 2025-11-13 | $352.45K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $5.17M 10-Q · filed 2025-08-14 | $4.02M 10-Q · filed 2025-08-14 | ||||
| 2024-09-30 | -$591.74K 10-Q · filed 2025-11-13 | -$416.81K 10-Q · filed 2024-11-14 | -$778.79K derived: sum of 2 quarters · filed 2025-11-13 | -$158.80K 10-Q · filed 2025-11-13 | $16.13K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$187.06K 10-Q · filed 2025-08-14 | $432.93K 10-Q · filed 2025-08-14 | ||||
| 2024-01-31 | $582.25K 10-K · filed 2026-03-31 | |||||
| 2023-09-30 | $515.77K 10-Q · filed 2024-11-14 | $587.63K derived: sum of 2 quarters · filed 2024-11-14 | $532.43K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $71.86K 10-Q · filed 2024-08-12 | $16.66K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |